Conmed (CNMD) Other Operating Expenses (2010 - 2025)

Conmed (CNMD) reported Other Operating Expenses of $460.0 million for Q4 2025, up 339.8% on a YoY basis from $104.6 million in Q4 2024, and up 346.59% quarter-over-quarter from $103.0 million in Q2 2025.

Conmed (CNMD) Other Operating Expenses (2010 - 2025) Analysis & Trends

Conmed has reported Other Operating Expenses for 6 years, with the latest figure at $460.0 million in Q4 2025.

  • For the quarter ending Q4 2025, Other Operating Expenses rose 339.8% year-over-year to $460.0 million; the trailing twelve-month figure through Mar 2026 stood at $563.0 million (up 79.21% YoY), and the FY2025 full-year result was $460.0 million, up 27.49% from the prior year.
  • Other Operating Expenses for Q4 2025 stood at $460.0 million, up from $103.0 million in the prior quarter.
  • The five-year high for Other Operating Expenses was $460.0 million in Q4 2025, with the low at $93.4 million in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn
10 Conmed 994.72 Mn 959.69 Mn 183.45 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 460.01 Mn
Jun 30, 2025 103.01 Mn
Mar 31, 2025 116.19 Mn
Dec 31, 2024 104.59 Mn
Jun 30, 2024 93.37 Mn
Dec 31, 2013 -12.93 Mn
Sep 30, 2013 6.04 Mn
Jun 30, 2013 3.50 Mn
Mar 31, 2013 3.39 Mn
Dec 31, 2012 3.53 Mn
Sep 30, 2012 2.66 Mn
Jun 30, 2012 1.78 Mn
Mar 31, 2012 1.99 Mn
Dec 31, 2011 60.60 Mn
Jun 30, 2011 98,000.00
Mar 31, 2011 694,000.00
Dec 31, 2010 915,000.00
Sep 30, 2010 291,000.00
Jun 30, 2010 970,000.00